WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 10'2101 Infant (under 12 months) mortality rate: 92
GDP / capita (US$): 15'3771 Child (under 5 years) mortality rate: 102

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 4'857  4'808  4'758  4'706  4'654  3'925  3'096  2'389 
Births 69  70  70  71  71  76  83  71 
Surviving infants 69  69  70  70  70  75  81  69 
Pop. less than 5 years 346  350  354  359  364  394  400  320 
Pop. less than 15 years 1'066  1'073  1'080  1'090  1'101  1'207  1'088  882 
Female 15-49 years 1'285  1'279  1'272  1'264  1'254  1'039  787  601 

Number of reported cases

(Click for retrospective incidence data for Costa Rica)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  76  1'000 
Mumps
ChartChart
  75  30  419 
Pertussis
ChartChart
  23  20  31  58  130  23  75  960 
Polio*
ChartChart
 
Rubella
ChartChart
  86 
Rubella (CRS)
ChartChart
  46 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  17 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Costa Rica)
Vaccine year result method % card seen                                                
BCG 2010  100  MICS   94  89  83  80  79  78  92  92  80 
DTP1 2010  99  MICS   94  96  93  91  94  92  90 
DTP3 2010  94  MICS   94  97  92  91  95  91  88  95  86 
DTP4          95  80 
IPV1          96  93  91 
HepB_BD          91  89  90 
HepB3 2010  93  MICS   94  97  92  91  94  91  89 
Hib3 2010  92  MICS   94  97  92  91  95  90  92 
JapEnc         
MCV1          93  93  95  91  90  82  90  60 
MCV2          87  90  90  92  95 
MenA         
PCV1          96  92  95 
PCV2          96  94  92  93  99* 
PCV3 2010  93  MICS   94  94  83  89 
Pol3 2010  95  MICS   94  97  92  91  95  90  80  95  86 
Rota1         
RotaC         
RCV1          93  93  95  91  90 
TT2plus 2010  MICS   94  81  77 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Costa Rica)
BCG
ChartChart
  89  83  80  79  78  92  92  80 
DTP1
ChartChart
  99  93  91  98  92  90  98  95 
DTP3
ChartChart
  97  92  91  95  91  88  95  86 
HepB3
ChartChart
  97  92  91  94  91  89 
HepB_BD
ChartChart
  91  90  89  90  90 
Hib3
ChartChart
  97  92  91  95  90  92 
MCV1
ChartChart
  93  93  95  91  90  82  90  60 
MCV2
ChartChart
  87  90  90  92  95 
PCV3
ChartChart
  94  94  83  94  89 
Pol3
ChartChart
  97  92  91  95  90  80  95  86 
RCV1
ChartChart
  93  93  95  91  90  82  90 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 81  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 77
From 80 to 89% 20
From 50 to 79% 4
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibIPV 2, 4, 6, 15 months; Yes
DTaPIPV 4 years; Yes
HepB_Adult 1st contact; +1, +6 months; Yes risk groups
HepB_Pediatric birth; 2, 6 months; Yes
Influenza_Adult 60 years; Yes and adults with chronical diseases, pregnant women, health care workers, and other risk groups
Influenza_Pediatric 6 months to 3 years Yes and children with risk factors and chronical diseases
MMR 15 months; 7 years; Yes
Pneumo_conj 2, 4, 15 months; Yes
Pneumo_ps >=60 years; Yes risk groups
Rabies Yes risk groups
Td 10 years; Yes
Tdap Yes CBAW
Varicella 15 months; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  No  No  No  No 
What years does the MYP cover? number 2015-2020  2015-2020  2015-2020        2'011 
Nº of districts with microplans that include activities to raise immunization coverage number   103  103 

System performance

Total Nº districts in country number 81  81  81  81  81  81  81 
Nº districts with DTP3 coverage >=80% number 78  72  77  69  54  70 
% of districts with DTP3 coverage >=80% From 0 to 100% 96  89  95  85  67  86 
Nº districts with measles (MCV1) coverage >=95% number 39  54  37  37  23  33 
% of districts with MCV1 coverage >=95% From 0 to 100% 48  67  46  46  28  41 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes    No  No    Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No    No  Yes    Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100    100  100  100  98  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  No  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.